Lenalidomide: a new therapy for multiple myeloma

被引：0
|
作者：
Sonneveld, Pieter [1 ]
Palumbo, Antonio [1 ]
机构：
[1] Erasmus MC, NL-3000 CA Rotterdam, Netherlands
来源：
EJHP PRACTICE | 2008年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The last decade has seen rapid improvements in the management of multiple myeloma, with a better understanding of the pathophysiology and prognostic markers of this heterogeneous malignancy. Lenalidomide has proven to be highly effective in patients whose disease has become resistant to conventional therapy.
引用
收藏
页码：58 / 61
页数：4
相关论文
共 50 条
  • [21] Bortezomib and lenalidomide as front-line therapy for multiple myeloma
    Zou, Yandun
    Lin, Mingzhen
    Sheng, Zhixin
    Niu, Shaona
    LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 2024 - 2031
  • [22] Thromboembolic events with lenalidomide-based therapy for multiple myeloma
    Menon, Smitha Patiyil
    Rajkumar, S. Vincent
    Lacy, Martha
    Falco, Patrizia
    Palumbo, Antonio
    CANCER, 2008, 112 (07) : 1522 - 1528
  • [23] Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma
    Sviggum, Hans P.
    Davis, Mark D. P.
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    ARCHIVES OF DERMATOLOGY, 2006, 142 (10) : 1298 - 1302
  • [24] Lenalidomide combination in multiple myeloma
    Pandey, Kaushal Raj
    LANCET ONCOLOGY, 2008, 9 (01): : 17 - 17
  • [25] Thalidomide and lenalidomide in multiple myeloma
    Mazumder, Amitabha
    Jagannath, Sundar
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (04) : 769 - 780
  • [26] Lenalidomide maintenance for multiple myeloma
    Brower, Vicki
    LANCET ONCOLOGY, 2012, 13 (06): : E238 - E238
  • [27] Lenalidomide in the treatment of multiple myeloma
    Rao, Kamakshi V.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (17) : 1799 - 1807
  • [28] Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma
    Richter, Joshua R.
    Bilotti, Elizabeth
    McBride, Laura
    Schmidt, Linda
    Gao, Zhijie
    Tufail, Madiha
    Anand, Palka
    McNeill, Ann
    Bednarz, Urszula
    Graef, Thorsten
    Vesole, David H.
    Siegel, David S.
    BLOOD, 2011, 118 (21) : 1706 - 1706
  • [29] A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022
    Gupta, Ravi Kumar
    Gupta, Ashish
    Hillengass, Jens
    Holstein, Sarah A.
    Suman, Vera J.
    Taneja, Alankrita
    McCarthy, Philip L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (05) : 457 - 469
  • [30] Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma
    Takakuwa, Teruhito
    Ohta, Kensuke
    Nakatani, Eiji
    Ito, Tomoki
    Kaneko, Hitomi
    Fuchida, Shin-Ichi
    Shimura, Yuji
    Yagi, Hideo
    Shibayama, Hirohiko
    Kanda, Junya
    Uchiyama, Hitoji
    Kosugi, Satoru
    Tanaka, Hirokazu
    Kawata, Eri
    Uoshima, Nobuhiko
    Ishikawa, Jun
    Shibano, Masaru
    Karasuno, Takahiro
    Shindo, Maki
    Shimizu, Yoshifumi
    Imada, Kazunori
    Kanakura, Yuzuru
    Kuroda, Junya
    Hino, Masayuki
    Nomura, Shosaku
    Takaori-Kondo, Akifumi
    Shimazaki, Chihiro
    Matsumura, Itaru
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (03) : 349 - 357
12345